Antihypertensive effect of formononetin through regulating the expressions of eNOS, 5-HT2A/1B receptors and α1-adrenoceptors in spontaneously rat arteries

European Journal of Pharmacology

Volumn 699, Issue 1-3, 2013, Pages 241-249

  Sun, Tao ^a   Wang, Jie ^a   Huang, Lin Hong ^a   Cao, Yong Xiao ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

1 adrenoceptor; 5 HT 2A 1B receptor; Antihypertension; Endothelial nitric oxide synthase; Formononetin

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN II; CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FORMONONETIN; MESSENGER RNA; NORADRENALIN; PHENYLEPHRINE; RENIN; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR;

ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG STRUCTURE; EXTRACELLULAR CALCIUM; GENE EXPRESSION; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MESENTERIC ARTERY; NONHUMAN; NORADRENALIN BLOOD LEVEL; NUCLEOTIDE SEQUENCE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEROTONIN BLOOD LEVEL; SPONTANEOUSLY HYPERTENSIVE RAT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYSTOLIC BLOOD PRESSURE; UPREGULATION; VASOCONSTRICTION; VASODILATATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOWN-REGULATION; HYPERTENSION; ISOFLAVONES; MALE; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE TYPE III; POLYSORBATES; RATS; RATS, INBRED SHR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, ALPHA-1; RNA, MESSENGER; UP-REGULATION;

EID: 84873737041     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.10.031     Document Type: Article

References (32)

1. M. Adner, L. Cantera, F. Ehlert, L. Nilsson, and L. Edvinsson Plasticity of contractile endothelin-B receptors in human arteries after organ culture Br. J. Pharmacol. 119 1996 1159 1166
2. J.W. Anderson, B.M. Johnstone, and M.E. Cook-Newell Meta-analysis of the effects of soy protein intake on serum lipids N. Engl. J. Med. 333 1995 276 282
3. P. August, T. Lenz, K.L. Ales, M.L. Druzin, T.G. Edersheim, J.M. Hutson, F.B. Muller, J.H. Laragh, and J.E. Sealey Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia Am. J. Obstet. Gynecol. 163 1990 1612 1621
4. L. Banie, G. Lin, H. Ning, G. Wang, T.F. Lue, and C.S. Lin Effects of estrogen, raloxifene and levormeloxifene on alpha1A-adrenergic receptor expression J. Urol. 180 2008 2241 2246
5. A. Broekaert, and T. Godfraind A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline- and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries Eur. J. Pharmacol. 53 1979 281 288
6. D.A. Calhoun Aldosteronism and hypertension Clin. J. Am. Soc. Nephrol. 1 2006 1039 1045
7. 2+ influx and release Vasc. Pharmacol. 45 2006 171 176
8. R.A. Coleman, W.L. Smith, and S. Narumiya International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol. Rev. 46 1994 205 229
9. M. Esler, G. Jennings, B. Biviano, G. Lambert, and G. Hasking Mechanism of elevated plasma noradrenaline in the course of essential hypertension J. Cardiovasc. Pharmacol. 8 Suppl 5 1986 S39 S43
10. A. Fawcett, M. Shembekar, J.S. Church, R. Vashisht, R.G. Springall, and D.M. Nott Smoking, hypertension, and colonic anastomotic healing; a combined clinical and histopathological study Gut 38 1996 714 718
11. M.B. Ganz, S.K. Pekar, M.C. Perfetto, and R.B. Sterzel Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture Am. J. Physiol. 255 1988 F898 F906
12. Gao, H., Dahlman-Wright, K., The gene regulatory networks controlled by estrogens. Mol. Cell. Endocrinol. 334, 83-90.
13. M.R. Goldberg, W. Tanaka, A. Barchowsky, T.E. Bradstreet, J. McCrea, M.W. Lo, E.J. McWilliams Jr., and T.D. Bjornsson Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers Hypertension 21 1993 704 713
14. F. Grover-Paez, and A.B. Zavalza-Gomez Endothelial dysfunction and cardiovascular risk factors Diabetes Res. Clin. Pract. 84 2009 1 10
15. R.D. Guarino, D.M. Perez, and M.T. Piascik Recent advances in the molecular pharmacology of the alpha 1-adrenergic receptors Cell. Signal. 8 1996 323 333
16. 2+ influx in rat vascular smooth muscle cells stimulated with 5-hydroxytryptamine Eur. J. Pharmacol. 427 2001 195 201
17. 1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: inverse association between gene expression and anxiety behavior in the open field Neuroscience 158 2009 456 464
18. S. Iwasa, J. Fan, T. Shimokama, M. Nagata, and T. Watanabe Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis Atherosclerosis 146 1999 93 100
19. 2 receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism Am. J. Respir. Crit. Care. Med. 166 2002 208 214
20. A.J. Kaumann, and F.O. Levy 5-hydroxytryptamine receptors in the human cardiovascular system Pharmacol. Ther. 111 2006 674 706
21. J. Li, Y.X. Cao, H. Liu, and C.B. Xu Enhanced G-protein coupled receptors-mediated contraction and reduced endothelium-dependent relaxation in hypertension Eur. J. Pharmacol. 557 2007 186 194
22. L.W. Lissin, and J.P. Cooke Phytoestrogens and cardiovascular health J. Am. Coll. Cardiol. 35 2000 1403 1410
23. G.A. Michelotti, D.T. Price, and D.A. Schwinn Alpha 1-adrenergic receptor regulation: basic science and clinical implications Pharmacol. Ther. 88 2000 281 309
24. H. Mu, Y.H. Bai, S.T. Wang, Z.M. Zhu, and Y.W. Zhang Research on antioxidant effects and estrogenic effect of formononetin from Trifolium pratense (red clover) Phytomedicine 16 2009 314 319
25. R.C. Siow, F.Y. Li, D.J. Rowlands, P. de Winter, and G.E. Mann Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes Free Radic. Biol. Med. 42 2007 909 925
26. T. Sun, R. Liu, and Y.X. Cao Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanisms Acta Pharmacol. Sin. 32 2011 1009 1018
27. H.J. Teede, B.P. McGrath, L. DeSilva, M. Cehun, A. Fassoulakis, and P.J. Nestel Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women Arterioscler. Thromb. Vasc. Biol. 23 2003 1066 1071
28. S.P. Tofovic, R.K. Dubey, and E.K. Jackson 2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats J. Pharmacol. Exp. Ther. 299 2001 973 977
29. Q.Y. Wang, Q.H. Meng, Z.T. Zhang, Z.J. Tian, and H. Liu Synthesis, solubility, lipids-lowering and liver-protection activities of sulfonated formononetin Yao Xue Xue Bao (Acta Pharm. Sin.) 44 2009 386 389
30. A. Wolthuis, A. Boes, H.P. Rodemann, and J. Grond Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells Kidney Int. 41 1992 124 131
31. J.H. Wu, Q. Li, M.Y. Wu, D.J. Guo, H.L. Chen, S.L. Chen, S.W. Seto, A.L. Au, C.C. Poon, G.P. Leung, S.M. Lee, Y.W. Kwan, and S.W. Chan Formononetin, an isoflavone, relaxes rat isolated aorta through endothelium-dependent and endothelium-independent pathways J. Nutr. Biochem. 21 2009 613 620
32. B.Q. Zhang, S.J. Hu, L.H. Qiu, J.H. Zhu, X.J. Xie, J. Sun, Z.H. Zhu, Q. Xia, and K. Bian Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine Vasc. Pharmacol. 46 2007 278 285